112.65
price down icon0.19%   -0.22
pre-market  Pre-mercato:  115.95   3.30   +2.93%
loading
Precedente Chiudi:
$112.87
Aprire:
$113.2
Volume 24 ore:
347.42K
Relative Volume:
0.37
Capitalizzazione di mercato:
$6.82B
Reddito:
$3.99B
Utile/perdita netta:
$463.16M
Rapporto P/E:
15.87
EPS:
7.1
Flusso di cassa netto:
$1.10B
1 W Prestazione:
+1.09%
1M Prestazione:
+4.78%
6M Prestazione:
-7.23%
1 anno Prestazione:
+3.34%
Intervallo 1D:
Value
$111.88
$113.96
Intervallo di 1 settimana:
Value
$111.13
$116.77
Portata 52W:
Value
$95.49
$148.06

Jazz Pharmaceuticals Plc Stock (JAZZ) Company Profile

Name
Nome
Jazz Pharmaceuticals Plc
Name
Telefono
353-1-634-7800
Name
Indirizzo
FIFTH FLOOR, WATERLOO EXCHANGE, DUBLIN
Name
Dipendente
2,800
Name
Cinguettio
@jazzpharma
Name
Prossima data di guadagno
2024-11-06
Name
Ultimi documenti SEC
Name
JAZZ's Discussions on Twitter

Confronta JAZZ con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Biotechnology icon
JAZZ
Jazz Pharmaceuticals Plc
112.65 6.74B 3.99B 463.16M 1.10B 7.10
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
458.49 121.30B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
545.53 61.60B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
320.52 41.17B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
566.14 34.35B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
291.93 27.29B 3.81B -644.79M -669.77M -6.24

Jazz Pharmaceuticals Plc Stock (JAZZ) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2025-07-15 Iniziato Deutsche Bank Buy
2025-03-07 Aggiornamento UBS Neutral → Buy
2025-02-26 Downgrade Cantor Fitzgerald Overweight → Neutral
2025-02-13 Aggiornamento Wells Fargo Equal Weight → Overweight
2024-12-12 Aggiornamento Morgan Stanley Equal-Weight → Overweight
2024-06-05 Iniziato Goldman Buy
2024-01-03 Iniziato Robert W. Baird Outperform
2023-11-27 Downgrade UBS Buy → Neutral
2023-09-29 Iniziato Raymond James Mkt Perform
2023-06-12 Ripresa Wells Fargo Equal Weight
2022-12-09 Aggiornamento Goldman Neutral → Buy
2022-06-14 Iniziato UBS Buy
2022-04-06 Downgrade Goldman Buy → Neutral
2021-11-19 Ripresa Goldman Buy
2021-10-07 Ripresa Jefferies Buy
2021-10-05 Iniziato Citigroup Buy
2021-09-23 Iniziato Needham Buy
2021-05-19 Ripresa JP Morgan Overweight
2021-04-07 Ripresa RBC Capital Mkts Outperform
2021-02-05 Reiterato H.C. Wainwright Buy
2021-02-03 Aggiornamento Piper Sandler Neutral → Overweight
2021-01-29 Downgrade Morgan Stanley Overweight → Equal-Weight
2020-12-16 Iniziato UBS Buy
2020-11-03 Reiterato H.C. Wainwright Buy
2020-10-09 Reiterato H.C. Wainwright Buy
2020-09-14 Downgrade Goldman Neutral → Sell
2020-09-14 Ripresa JP Morgan Overweight
2020-08-06 Aggiornamento Morgan Stanley Equal-Weight → Overweight
2020-07-28 Aggiornamento Wolfe Research Peer Perform → Outperform
2020-07-23 Aggiornamento H.C. Wainwright Neutral → Buy
2020-04-06 Iniziato Jefferies Buy
2020-03-12 Aggiornamento Bernstein Mkt Perform → Outperform
2020-01-08 Iniziato Goldman Neutral
2019-08-21 Downgrade Piper Jaffray Overweight → Neutral
2019-06-11 Iniziato Barclays Overweight
2019-03-20 Iniziato SunTrust Buy
2018-12-14 Iniziato Wolfe Research Peer Perform
2018-11-08 Reiterato B. Riley FBR Buy
2018-08-08 Reiterato Stifel Buy
2018-07-11 Downgrade Morgan Stanley Overweight → Equal-Weight
2018-03-23 Reiterato H.C. Wainwright Neutral
2018-03-19 Aggiornamento Morgan Stanley Equal-Weight → Overweight
Mostra tutto

Jazz Pharmaceuticals Plc Borsa (JAZZ) Ultime notizie

pulisher
03:17 AM

What analysts say about Jazz Pharmaceuticals plc stockBreakthrough financial growth - jammulinksnews.com

03:17 AM
pulisher
Jul 21, 2025

Is Jazz Pharmaceuticals plc a good long term investmentAccelerated wealth expansion - Autocar Professional

Jul 21, 2025
pulisher
Jul 21, 2025

What drives Jazz Pharmaceuticals plc stock priceTremendous growth opportunities - Autocar Professional

Jul 21, 2025
pulisher
Jul 21, 2025

Lacklustre Performance Is Driving Jazz Pharmaceuticals plc's (NASDAQ:JAZZ) Low P/E - simplywall.st

Jul 21, 2025
pulisher
Jul 20, 2025

Jazz Pharmaceuticals plc Stock Analysis and ForecastUnbelievable profit margins - PrintWeekIndia

Jul 20, 2025
pulisher
Jul 18, 2025

Pharma 50: The top pharma companies in the world for 2025 - drugdiscoverytrends.com

Jul 18, 2025
pulisher
Jul 17, 2025

Zymeworks to Report Second Quarter 2025 Financial Results and Host Conference Call on August 7, 2025 - GlobeNewswire Inc.

Jul 17, 2025
pulisher
Jul 17, 2025

Jazz Pharmaceuticals (JAZZ) Highlights Growth at Goldman Sachs Healthcare Conference - MSN

Jul 17, 2025
pulisher
Jul 15, 2025

Jazz Pharmaceuticals Stock Offers Buying Opportunity After Slump, Deutsche Bank Says - MarketScreener

Jul 15, 2025
pulisher
Jul 15, 2025

Deutsche Bank initiates Jazz Pharmaceuticals stock with Buy rating By Investing.com - Investing.com Nigeria

Jul 15, 2025
pulisher
Jul 15, 2025

Deutsche Bank Initiates Jazz Pharmaceuticals at Buy With $152 Price Target - MarketScreener

Jul 15, 2025
pulisher
Jul 14, 2025

What makes Jazz Pharmaceuticals plc stock price move sharplyFree Capital Allocation Plans - beatles.ru

Jul 14, 2025
pulisher
Jul 14, 2025

Ireland: Renee Gala elected CEO at Jazz Pharma - Investors in Healthcare

Jul 14, 2025
pulisher
Jul 11, 2025

Jazz names new CEO; Ultragenyx, Mereo shares slide on trial update - BioPharma Dive

Jul 11, 2025
pulisher
Jul 11, 2025

Jazz Pharmaceuticals Appoints Renee Gala as New CEO - The Globe and Mail

Jul 11, 2025
pulisher
Jul 11, 2025

Jazz Pharmaceuticals names Renee Gala as next CEO By Investing.com - Investing.com South Africa

Jul 11, 2025
pulisher
Jul 11, 2025

Jazz Pharmaceuticals names Renee Gala as next CEO - Investing.com Australia

Jul 11, 2025
pulisher
Jul 11, 2025

1 Profitable Stock with Solid Fundamentals and 2 to Brush Off - Yahoo Finance

Jul 11, 2025
pulisher
Jul 10, 2025

Jazz Looks To Block Avadel From Asking For Sleep Drug OK - Law360

Jul 10, 2025
pulisher
Jul 10, 2025

Avadel Pharmaceuticals Receives Unanimous Appeals Court Affirmation for LUMRYZ FDA Approval - Insider Monkey

Jul 10, 2025
pulisher
Jul 10, 2025

Jazz Pharmaceuticals Names Renee Gala as President & CEO - Contract Pharma

Jul 10, 2025
pulisher
Jul 10, 2025

Jazz Pharmaceuticals names Renee Gala as president and CEO - MarketScreener

Jul 10, 2025
pulisher
Jul 10, 2025

Jazz Pharmaceuticals Names Renee Gala as President and Chief Executive Officer - PR Newswire

Jul 10, 2025
pulisher
Jul 07, 2025

Jazz Pharmaceuticals Gets UBS Buy Rating After Strong ASCO 2025 Trial Results - MSN

Jul 07, 2025
pulisher
Jul 07, 2025

Jazz Pharmaceuticals: I See Big Potential In This Stock As An Investor (NASDAQ:JAZZ) - Seeking Alpha

Jul 07, 2025
pulisher
Jul 06, 2025

10 Best High Short Interest Stocks With Huge Upside Potential - Insider Monkey

Jul 06, 2025
pulisher
Jul 06, 2025

Jazz Pharmaceuticals’ Ziihera Receives Conditional European Approval for Advanced Biliary Tract Cancer - Yahoo Finance

Jul 06, 2025
pulisher
Jul 03, 2025

Jazz Pharmaceuticals gets EU nod for Ziihera - MSN

Jul 03, 2025
pulisher
Jul 01, 2025

Jazz Pharmaceuticals Receives European Commission Marketing Auth - GuruFocus

Jul 01, 2025
pulisher
Jul 01, 2025

Breakthrough: EU Approves First Targeted Therapy for Aggressive Bile Duct Cancer with 41% Response Rate - Stock Titan

Jul 01, 2025
pulisher
Jun 30, 2025

ASL pushes for board shakeup at Avadel over handling of sleep drug rollout - Reuters

Jun 30, 2025
pulisher
Jun 27, 2025

The 5 Most Interesting Analyst Questions From Jazz Pharmaceuticals’s Q1 Earnings Call - Yahoo Finance

Jun 27, 2025
pulisher
Jun 19, 2025

FDA Approvals and Clinical Trials Impacting Narcolepsy - openPR.com

Jun 19, 2025

Jazz Pharmaceuticals Plc Azioni (JAZZ) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading
$21.69
price down icon 0.87%
$35.65
price up icon 0.17%
$102.78
price up icon 0.22%
$26.34
price up icon 0.53%
$108.91
price down icon 1.01%
biotechnology ONC
$291.93
price down icon 0.89%
Capitalizzazione:     |  Volume (24 ore):